1 / 4

Neuroscience Antibodies and Assays Market Research Report till 2025 with Trends and Forecast

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. <br><br>Request for a sample copy of the ‘Neuroscience Antibodies and Assays Market’ report @: <br>https://www.globalmarketestimates.com/neuroscience-antibodies-and-assays-market/ <br>

Mayuri91
Download Presentation

Neuroscience Antibodies and Assays Market Research Report till 2025 with Trends and Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS Ankita Roy, Treesha Banerjee and Liza D’souza from Global Market Estimates throw the spotlight on the growing Neuroscience Antibodies and AssaysMarket. Neuroscience Antibodies and Assays MarketInsights The Neuroscience Antibodies and Assays market is projected to grow at a high CAGR during the forecast period. The market is driven by growing investment in neuroscience research, high growth in the pharmaceutical and biotechnology industry and increasing investment in the field. Growing incidence of neurological diseases is also estimated to have a positive impact on the market during the forecast period. However, the high cost of these products and concerns with respect to their qualityare somefactorslikelytohindermarketgrowthuptoacertainextent. NeuroscienceAntibodiesandAssaysMarket:ByProduct The Neuroscience Antibodies and Assays market can be segmented based on basis of product into consumables and instruments. The consumables segment is expected to hold the largest market share in terms of revenue and is also projected to grow at the highest CAGR during the forecast period. The consumables segment can be further classified into reagents, antibodies, and assays kits. Among these, the reagents segment is expected to hold the largest market share owing to the high consumption of reagents in multiple routine assays and techniques. Frequent purchases of consumables and Government initiatives in genomics and proteomics research are the major factors drivinggrowthintheconsumablessegmentduringtheforecastperiod. Neuroscience Antibodies and Assays Market: ByTechnology ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

  2. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS The Neuroscience Antibodies and Assays market can be segmented based on technology into immunoassays/immunochemistry, molecular diagnostics, and clinical chemistry among others. The immunoassays/immunochemistry segment is expected to grow at the highest CAGR during the forecastperiodandcanbeattributedto research anddevelopmentactivitiesinthedomain NeuroscienceAntibodiesandAssaysMarket:ByApplication The Neuroscience Antibodies and Assays market can be segmented on the basis of application into drug discovery & development, research, and IVD among others. The drug discovery & development segment is expected to largest market share in terms of revenue owing to growing research and developmentexpenditure. NeuroscienceAntibodiesandAssaysMarket:ByEndUser The Neuroscience Antibodies and Assays market can be segmented into pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers among others. the pharmaceutical and biotechnology companies segment is expected to hold the largest market share in terms of revenue owing to the presence of large number of pharmaceutical players in the market and the high uptake of neuroscience antibodies in the drug discovery and development process. Neuroscience Antibodies and Assays Market: RegionalInsights Asia is estimated to grow at the highest CAGR during the forecast period. The high growth can be attributed to favorable regulatory policies and the growing incidence of neurological diseases. These factors have generated numerous market opportunities for companies, which has led to a rise in the number of market players in the region. Further, rising investment in the life sciences sector is projected to further augment marketgrowth. Neuroscience Antibodies and Assays Market: End-UseLandscape ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

  3. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase neuroscience antibodies and assays over the coming years. Some companies which are currently using neuroscience antibodies and assays and are likely to use in future are Roche, Novartis andGilead Sciences among others. Neuroscience Antibodies and Assays Market: VendorLandscape The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence ofcompanies. NeuroscienceAntibodiesandAssaysMarket: Share&CompetitorAnalysis Some of the key players operating in the Neuroscience Antibodies and Assays markets are Abcam, Thermo Fischer Scientific, Bio-Rad, Merck KGaA,Genscript, Cell Signaling Technology, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Tecan, Siemens and F. Hoffmann-La Roche amongothers. On October 5, 2018, Piramal Pharma Solutions Announced the Launch of Xcelerate Integrated Solutions In April 2018, Thermo Fischer Scientific announced its firstcloud-enabled biological safety cabinet In January 2018, Thermo Fischer Scientific expanded its oncomineprofile • ThereportsegmentstheNeuroscienceAntibodiesandAssaysMarketonthebasisof: • ByProduct • Consumables • Instruments • ByTechnology • Immunoassay(Elisa) ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

  4. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS • MolecularDiagnostics • ClinicalChemistry • ByApplication • Drug Discovery &Development • Research • IVD • By EndUser • Pharmaceutical & BiotechnologyCompanies • Academic & ResearchInstitutes • Hospitals & DiagnosticCenters • ByRegion: • NorthAmerica • Europe • AsiaPacific • Central & SouthAmerica • Middle East &Africa * This article contains text from the ‘Global Neuroscience Antibodies and Assays Market– Forecast to 2025’ report For more information or to buy the report, please visit: https://www.globalmarketestimates.com/neuroscience-antibodies-and-assays-market/ *Check our annual research partnership service at: https://www.globalmarketestimates.com/annual-research-partnership-services/ ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

More Related